Richard Garr - curasan AG Insider

curasan AG -- Germany Stock  

EUR 1.05  0.01  0.96%

President CEO, General Counsel, Director

Mr. I. Richard Garr J.D. is Director of the Company. He is no longer Chief Financial Officer of the Company. effective May 18 2015. Mr. Garr was previously an attorney with Beli Weil Jacobs the BG Companies and Circle Management Companies. Mr. Garr is a graduate of Drew University and the Columbus School of Law The Catholic University of America . Additionally he was a founder and current Board Trustee of the First Star Foundation a childrens charity focused on abused childrens issues a founder of The Starlight Foundation Mid Atlantic chapter which focuses on helping seriously ill children and is a past Honorary Chairman of the Brain Tumor Society.
Age: 61  CEO Since 2016      
49 6027 40 900 51

Management Efficiency

The company has return on total asset (ROA) of (15.5) % which means that it has lost $15.5 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (39.32) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 695 K in total debt with debt to equity ratio (D/E) of 10.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. curasan AG has Current Ratio of 1.18 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Found 1 records

CEO Since

Liam CondonBayer Aktiengesellschaft

Entity Summary

curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company was founded in 1988 and is based in Kleinostheim, Germany. curasan AG operates under Healthcare Products classification in Germany and traded on Frankfurt Stock Exchange. It employs 36 people.curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 36 people.

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Hide  View All  NextLaunch Correlation Analysis

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add curasan AG to your portfolio

Top Management

curasan AG Leadership Team
William Oldaker, Director
David Castaneda, Executive
Stanley Westreich, Director
Karl Johe, Chairman
Scott Ogilvie, Director
Catherine Sohn, Director, Ph.D
Richard Garr, CEO
Richard Daly, CEO, MBA
Sandford Smith, Director
Jonathan Jones, CFO

Stock Performance

curasan AG Performance Indicators